Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[Description of an isoniazid-resistant tuberculosis outbreak in a block of apartments].

Ruíz de Zárate B, Gomez-Pastrana D, Pérez-Escolano E, Aragón Fernández C, López Prieto MD.

An Pediatr (Barc). 2017 Nov;87(5):292-293. doi: 10.1016/j.anpedi.2017.03.002. Epub 2017 Apr 14. Spanish. No abstract available.

2.
3.

Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.

Livengood JR, Sigler TG, Foster LR, Bobst JG, Snider DE Jr.

JAMA. 1985 May 17;253(19):2847-9.

PMID:
3989958
4.

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM.

PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.

5.

Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in Sweden.

Sandegren L, Groenheit R, Koivula T, Ghebremichael S, Advani A, Castro E, Pennhag A, Hoffner S, Mazurek J, Pawlowski A, Kan B, Bruchfeld J, Melefors Ö, Källenius G.

PLoS One. 2011 Jan 31;6(1):e16647. doi: 10.1371/journal.pone.0016647.

6.

Outbreak of isoniazid resistant tuberculosis in north London.

Ruddy MC, Davies AP, Yates MD, Yates S, Balasegaram S, Drabu Y, Patel B, Lozewicz S, Sen S, Bahl M, James E, Lipman M, Duckworth G, Watson JM, Piper M, Drobniewski FA, Maguire H.

Thorax. 2004 Apr;59(4):279-85.

7.

Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014.

Smith CM, Trienekens SC, Anderson C, Lalor MK, Brown T, Story A, Fry H, Hayward AC, Maguire H.

Euro Surveill. 2017 Feb 23;22(8). pii: 30467. doi: 10.2807/1560-7917.ES.2017.22.8.30467.

8.

Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.

Valvatne H, Syre H, Kross M, Stavrum R, Ti T, Phyu S, Grewal HM.

J Antimicrob Chemother. 2009 Oct;64(4):694-701. doi: 10.1093/jac/dkp292. Epub 2009 Aug 26.

PMID:
19710078
9.

Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study.

Casali N, Broda A, Harris SR, Parkhill J, Brown T, Drobniewski F.

PLoS Med. 2016 Oct 4;13(10):e1002137. doi: 10.1371/journal.pmed.1002137. eCollection 2016 Oct.

10.

Isoniazid resistant tuberculosis in a school outbreak: the protective effect of BCG.

Shannon A, Kelly P, Lucey M, Cooney M, Corcoran P, Clancy L.

Eur Respir J. 1991 Jul;4(7):778-82.

PMID:
1954998
11.

When is an outbreak not an outbreak? Fit, divergent strains of Mycobacterium tuberculosis display independent evolution of drug resistance in a large London outbreak.

Shorten RJ, McGregor AC, Platt S, Jenkins C, Lipman MC, Gillespie SH, Charalambous BM, McHugh TD.

J Antimicrob Chemother. 2013 Mar;68(3):543-9. doi: 10.1093/jac/dks430. Epub 2012 Nov 5.

PMID:
23129727
12.

Outbreak of drug-resistant tuberculosis with second-generation transmission in a high school in California.

Ridzon R, Kent JH, Valway S, Weismuller P, Maxwell R, Elcock M, Meador J, Royce S, Shefer A, Smith P, Woodley C, Onorato I.

J Pediatr. 1997 Dec;131(6):863-8.

PMID:
9427891
13.

[A case of isoniazid-resistant tuberculosis diagnosed during chemoprophylaxis with isoniazid].

Toyota M, Morioka S.

Kekkaku. 2001 Oct;76(10):663-6. Japanese.

PMID:
11712387
14.

Large outbreak of isoniazid-monoresistant tuberculosis in London, 1995 to 2006: case-control study and recommendations.

Maguire H, Brailsford S, Carless J, Yates M, Altass L, Yates S, Anaraki S, Charlett A, Lozewicz S, Lipman M, Bothamley G.

Euro Surveill. 2011 Mar 31;16(13). pii: 19830.

15.

Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis.

Asch S, Knowles L, Rai A, Jones BE, Pogoda J, Barnes PF.

Am J Respir Crit Care Med. 1996 May;153(5):1708-10.

PMID:
8630625
16.

Management of an outbreak of tuberculosis in a small community.

Allos BM, Genshelmer KF, Bloch AB, Parrotte D, Horan JM, Lewis V, Schaffner W.

Ann Intern Med. 1996 Jul 15;125(2):114-7.

PMID:
8678365
17.

A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.

Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, Sharp V, Hewlett D Jr, Brudney K, Alland D, Kreisworth BN.

JAMA. 1996 Oct 16;276(15):1229-35.

PMID:
8849750
18.

Global and Regional Burden of Isoniazid-Resistant Tuberculosis.

Yuen CM, Jenkins HE, Rodriguez CA, Keshavjee S, Becerra MC.

Pediatrics. 2015 Jul;136(1):e50-9. doi: 10.1542/peds.2015-0172. Epub 2015 Jun 1. Review.

19.

[Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].

Jiang X, Gao F, Zhang WH, Hu ZY, Wang HH.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):427-31. Chinese.

PMID:
17673015
20.

Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.

Schaaf HS, Victor TC, Engelke E, Brittle W, Marais BJ, Hesseling AC, van Helden PD, Donald PR.

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):203-5.

PMID:
17294161

Supplemental Content

Support Center